Literature DB >> 31571267

Biological models in multiple sclerosis.

Alfredo Sanabria-Castro1,2, Marietta Flores-Díaz3, Alberto Alape-Girón3.   

Abstract

Considering the etiology of multiple sclerosis (MS) is still unknown, experimental models resembling specific aspects of this immune-mediated demyelinating human disease have been developed to increase the understanding of processes related to pathogenesis, disease evolution, evaluation of therapeutic interventions, and demyelination and remyelination mechanisms. Based on the nature of the investigation, biological models may include in vitro, in vivo, and ex vivo assessments. Even though these approaches have disclosed valuable information, every disease animal model has limitations and can only replicate specific features of MS. In vitro and ex vivo models generally do not reflect what occurs in the organism, and in vivo animal models are more likely used; nevertheless, they are able to reproduce only certain stages of the disease. In vivo MS disease animal models in mammals include: experimental autoimmune encephalomyelitis, viral encephalomyelitis, and induced demyelination. This review examines and describes the most common biological disease animal models for the study of MS, their specific characteristics and limitations.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  demyelination; disease animal models; experimental autoimmune encephalomyelitis; viral encephalomyelitis

Mesh:

Year:  2019        PMID: 31571267     DOI: 10.1002/jnr.24528

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Establishment of Human Induced Pluripotent Stem Cells from Multiple Sclerosis Patients.

Authors:  Onur Can Begentas; Dilara Koc; Erkan Kiris
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases.

Authors:  Erkan Kiris
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  An in vivo accelerated developmental myelination model for testing promyelinating therapeutics.

Authors:  Karen Lariosa-Willingham; Kimmo K Lehtimäki; Diana Miszczuk; Dmitri Leonoudakis; Timo Bragge; Laura Tolppanen; Antti Nurmi; Megan Flanagan; Janelle Gibson; David Wilson; Jennifer Stratton
Journal:  BMC Neurosci       Date:  2022-05-25       Impact factor: 3.264

Review 4.  Implication of Contactins in Demyelinating Pathologies.

Authors:  Ilias Kalafatakis; Maria Savvaki; Theodora Velona; Domna Karagogeos
Journal:  Life (Basel)       Date:  2021-01-13

5.  Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.

Authors:  Jinming Han; Keying Zhu; Kai Zhou; Ramil Hakim; Sreenivasa Raghavan Sankavaram; Klas Blomgren; Harald Lund; Xing-Mei Zhang; Robert A Harris
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.